Dongsheng Fan

机构：Peking University, Peking University Third Hospital · ORCID：0000-0002-6679-0864

发表论文 149 篇 · 总被引 2214 次 · h-index 24

代表论文

• Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4·5 h after stroke onset (PROST-2): a phase 3, open-label, non-inferiority, randomised controlled trial (2024 · The Lancet Neurology · 被引 42)
• Disruption of ER ion homeostasis maintained by an ER anion channel CLCC1 contributes to ALS-like pathologies (2023 · Cell Research · 被引 38)
• Lipids and amyotrophic lateral sclerosis: A two‐sample Mendelian randomization study (2023 · European Journal of Neurology · 被引 28)
• Gene therapy breakthroughs in ALS: a beacon of hope for 20% of ALS patients (2025 · Translational Neurodegeneration · 被引 15)
• A Multicenter Study of Hereditary Transthyretin Amyloidosis in China (2025 · Annals of Neurology · 被引 9)
• Smell loss is associated with cognitive impairment in amyotrophic lateral sclerosis patients (2024 · CNS Neuroscience & Therapeutics · 被引 6)